Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00096122 · FLOW

Participant flow

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · Source last updated 2014-05-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Cytarabine 1.5 g/m\^2 and Idarubicin 12 mg/m\^2 intravenous (IV) continuously on days 1-3 (or 1-4), with Oral Tipifarnib 200/300 twice daily on days 1-21, repeats every 21 days.
    id
    FG000
    title
    Idarubicin, Cytarabine + Tipifarnib
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
One participant enrolled was excluded from the study.
recruitment Details
Recruitment Period: 9/16/2004 to 9/22/2006. All patients registered at The University of Texas M.D. Anderson Cancer Center.
Complete source fields
groups
  1. description
    Cytarabine 1.5 g/m\^2 and Idarubicin 12 mg/m\^2 intravenous (IV) continuously on days 1-3 (or 1-4), with Oral Tipifarnib 200/300 twice daily on days 1-21, repeats every 21 days.
    id
    FG000
    title
    Idarubicin, Cytarabine + Tipifarnib
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        95
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
One participant enrolled was excluded from the study.
recruitment Details
Recruitment Period: 9/16/2004 to 9/22/2006. All patients registered at The University of Texas M.D. Anderson Cancer Center.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice